未登录.png)
分享.png)
收藏Efficacy and safety of upadacitinib dose escalation and reduction in adults with moderate-to-severe atopic dermatitis: results of a randomized blinded treat-to-target multicentre phase IIIb/IV study (Flex Up)中重度特应性皮炎患者中乌帕替尼剂量增加和减少的疗效与安全性：一项随机、盲法、治至目标、多中心IIIb/IV期研究（Flex Up）的结果
Gooderham, Melinda; Torres, Tiago; Imafuku, Shinichi; Rademaker, Marius; Prajapati, Vimal H.; Tsianakas, Athanasios; Murrell, Dedee F.; Owczarek, Witold; Han, Yu; Lee, Wan-Ju; Levy, Gweneth; Ibrahim, Nadia; Moreira, Alvaro; Shams, Kave 分享 收藏 Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study (vol 14, pg 3273, 2024)Warren, Richard B.; Pavlovsky, Lev; Costanzo, Antonio; Bukhalo, Michael; Korman, Neil J.; Huang, Yu-Huei; Kokolakis, Georgios; Pinter, Andreas; Ibrahim, Nadia; Zheng, Yanbing; Drogaris, Leonidas; Stakias, Vassilis; Soliman, Ahmed M.; Rubant, Simone; Thaci, Diamant 分享 收藏 Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) StudyRisankizumab在对Secukinumab或Ixekizumab反应欠佳的牛皮癣患者中的疗效和安全性: 3b期，开放标签，单臂 (aIMM) 研究的结果Warren, Richard B.; Pavlovsky, Lev; Costanzo, Antonio; Bukhalo, Michael; Korman, Neil J.; Huang, Yu-Huei; Kokolakis, Georgios; Pinter, Andreas; Ibrahim, Nadia; Zheng, Yanbing; Drogaris, Leonidas; Stakias, Vassilis; Soliman, Ahmed M.; Rubant, Simone; Thaci, Diamant 分享 收藏 Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up)Silverberg, Jonathan, I; Bunick, Christopher G.; Hong, H. Chih-ho; Mendes-Bastos, Pedro; Gold, Linda Stein; Costanzo, Antonio; Ibrahim, Nadia; Sancho, Cristina; Wu, Xiaoqiang; Han, Yu; Levy, Gweneth; Altman, Kathy; Calimlim, Brian; Eyerich, Kilian 分享 收藏 Efficacy and safety of upadacitinib vs dupliumab in adults and adolescents with moderate-to-severe atopic dermatitis: results of an open-label, efficacy assessor-blinded head-to-head phase 3b/4 study (Level Up)Silverberg, Jonathan, I; Bunick, Christopher; Hong, H. Chih-ho; Mendes-Bastos, Pedro; Gold, Linda Stein; Costanzo, Antonio; Ibrahim, Nadia; Sancho, Cristina; Wu, Xiaoqiang; Han, Yu; Levy, Gweneth; Altman, Kathy; Eyerich, Kilian 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
OAAI.png){kind=icon}
